Published on January 10, 2016

Texas Woman Seeks Compensation for Zofran-Related Birth Defects

Texas Lady Seeks Payment for Zofran-Related Birth Defects
In a recently submitted claim, a Texas woman asserts that congenital defects she has coped with because birth are the outcome of her mother’s use of anti-nausea medication Zofran (ondansetron) during pregnancy. Declaring neglect, scams, misstatement and breaches of express and suggested warranties on the part of drug maker GlaxoSmithKline (GSK), the complainant is seeking substantial financial compensation for the harm she has actually sustained. Filed in the U.S. District Court for the Northern Dist

Leave a Comment

Your email address will not be published. Required fields are marked *